Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT2306 vs Cosentyx in Moderate to Severe Plaque Psoriasis
CTR20221780Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Jul 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of BAT2306 in psoriasis, sponsored by Bio-Thera Solutions, Ltd.. Started Jul 2022; status: completed.
02
Drugs
BAT2306
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20221780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221780.